Metformin, through the induction of 5' AMP-activated protein kinase and subsequently insulin sensitivity, has been widely used as a therapeutic agent in various conditions, including type 2 diabetes mellitus, PCOS and gestational diabetes (Reference Rice, Elia and Jawad42)
Many individuals with type 2 diabetes or obesity take multiple medications that independently cause xerostomia, including antihypertensives (particularly diuretics), antidepressants, antihistamines, and other medications with anticholinergic properties
By acting on appetite centers in the brain, especially the hypothalamus, semaglutide reduces hunger, cravings, and desire to eat
10.2147/DDDT.S356307 [DOI] [PMC free article] [PubMed] [Google Scholar] 348.Qin, D
Comparative effectiveness of once-weekly glucagon-like peptide-1 receptor agonists with regard to 6-month glycaemic control and weight outcomes in patients with type 2 diabetes
Sterile technique: All IV nutrition therapy preparation and administration must follow aseptic protocols